A phase 2a, randomized, placebo-controlled, dose-ranging study to evaluate the safety and efficacy of ptc518 in subjects with Huntington's disease - PIVOT HD
Phase 1 open-label, crossover study to evaluate the effect of food on the pharmacokinetics and safety of a single oral dose of PTC518 in healthy volunteers. - PTC518 food effect study.
Start Date26 Apr 2022
Sponsor / Collaborator-
100 Clinical Results associated with splicing factor x HTT
Login to view more data
100 Translational Medicine associated with splicing factor x HTT
Login to view more data
0 Patents (Medical) associated with splicing factor x HTT
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.